Pfizer on Thursday announced it is seeking full Food and Drug Administration approval for its oral Covid-19 antiviral Paxlovid, an anticipated move that could boost confidence in the drug and sets the stage for the company to market directly to consumers.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,